(Q43443469)

23 November 2017

title

Insulin-like growth factors I and II in evaluation of growth retardation (English)

1 reference

23 November 2017

1 reference

1

Rosenfeld RG

1 reference

23 November 2017

4

Hintz RL

1 reference

23 November 2017

2

Wilson DM

1 reference

23 November 2017

Lee PD

3

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 September 1986

1 reference

The Journal of Pediatrics

23 November 2017

published in

1 reference

23 November 2017

volume

109

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

428-433

1 reference

Primary structure of human insulin-like growth factor II.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

A Radioimmunoassay for Insulin-like Growth Factor II Specific for the C-Peptide Region*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Somatomedin-C and the assessment of growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Somatomedins in Adolescence: A Cross-Sectional Study of the Effect of Puberty on Plasma Insulin-Like Growth Factor I and II Levels*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Relationship of somatomedin-C concentrations to pubertal changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Reduction of plasma immunoreactive somatomedin C during fasting in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

The use of a commercially available somatomedin-C radioimmunoassay in patients with disorders of growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Differences in somatomedin-C between short-normal subjects and those of normal height

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Children with normal-variant short stature: treatment with human growth hormone for six months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Growth hormone treatment for short stature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Prospective clinical trial of human growth hormone in short children without growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

Biosynthetic methionyl human growth hormones is biologically active in adult man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980112-3

10.1016/S0022-3476(86)80112-3

7 January 2021

Identifiers

DOI

1 reference

23 November 2017

1 reference